+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genmab AS - logo

Genmab is a leading biotechnology company that focuses on developing innovative antibody products. Arzerra is the company’s first marketed antibody and is approved to treat chronic lymphocytic leukemia (CLL) patients in all major markets. Another product, Darzalex, has been approved in the United States for the treatment of patients with multiple myeloma. Genmab was founded in Copenhagen, Denmark in 1999 and employs around 200 people.

Small-Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Small-Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 574 Pages
  • Global
From
AI-Enabled Drug Discovery and Clinical Trials Market Report 2025-2035 - Product Thumbnail Image

AI-Enabled Drug Discovery and Clinical Trials Market Report 2025-2035

  • Report
  • April 2025
  • 285 Pages
  • Global
From
Chronic Lymphocytic Leukemia Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Thumbnail Image

Chronic Lymphocytic Leukemia Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • February 2024
  • 184 Pages
  • Global
From
T-Cell Therapy Market by Type of Therapy, Target Indication, Target Antigen, Company Size, Geographical Regions, Leading Players and Sales Forecast of Therapies, Industry Trends and Global Forecasts to 2035 - Product Thumbnail Image

T-Cell Therapy Market by Type of Therapy, Target Indication, Target Antigen, Company Size, Geographical Regions, Leading Players and Sales Forecast of Therapies, Industry Trends and Global Forecasts to 2035

  • Report
  • March 2025
  • 1048 Pages
  • Global
From
TIL Therapies Market Industry Trends and Global Forecasts to 2035, by Target Indication, Key Players and Key Geographical Regions - Product Thumbnail Image

TIL Therapies Market Industry Trends and Global Forecasts to 2035, by Target Indication, Key Players and Key Geographical Regions

  • Report
  • February 2025
  • 315 Pages
  • Global
From
Cancer Monoclonal Antibodies Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) - Product Thumbnail Image

Cancer Monoclonal Antibodies Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • Report
  • August 2022
  • 115 Pages
  • Global
From
EPKINLY Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

EPKINLY Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • November 2023
  • 30 Pages
  • Global
From
TCR Therapy Market Industry Trends and Global Forecasts to 2035, by Target Indication, Target Antigen, Key Players and Key Geographies - Product Thumbnail Image

TCR Therapy Market Industry Trends and Global Forecasts to 2035, by Target Indication, Target Antigen, Key Players and Key Geographies

  • Report
  • January 2025
  • 363 Pages
  • Global
From
Antibody Drug Conjugate Market Industry Trends and Global Forecasts to 2035, by Target Disease Indication, Therapeutic Area, Linker, Payload, Target Antigens and Key Geographical Regions - Product Thumbnail Image

Antibody Drug Conjugate Market Industry Trends and Global Forecasts to 2035, by Target Disease Indication, Therapeutic Area, Linker, Payload, Target Antigens and Key Geographical Regions

  • Report
  • November 2024
  • 716 Pages
  • Global
From
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 1560 Pages
  • Global
From
Multiple Myeloma (Kahler Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Multiple Myeloma (Kahler Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 1182 Pages
  • Global
From
Antibody Drug Conjugates Market Report 2025-2035 - Product Thumbnail Image

Antibody Drug Conjugates Market Report 2025-2035

  • Report
  • December 2024
  • 342 Pages
  • Global
From
Non-Hodgkin Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Non-Hodgkin Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 1814 Pages
  • Global
From
Chronic Lymphocytic Leukemia (CLL) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Chronic Lymphocytic Leukemia (CLL) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 628 Pages
  • Global
From
Central Nervous System Collaboration and Licensing Deals 2020-2025 - Product Thumbnail Image

Central Nervous System Collaboration and Licensing Deals 2020-2025

  • Report
  • April 2025
  • 400 Pages
  • Global
From
Richter's Syndrome- Pipeline Insight, 2025 - Product Thumbnail Image

Richter's Syndrome- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Rybrevant Bispecific Antibody Patent, Sales & Clinical Trials Outlook 2028 - Product Thumbnail Image

Rybrevant Bispecific Antibody Patent, Sales & Clinical Trials Outlook 2028

  • Report
  • October 2021
  • 78 Pages
  • Global
From
Acute Lymphoblastic Leukemia Therapeutics Market Report and Forecast 2024-2032 - Product Thumbnail Image

Acute Lymphoblastic Leukemia Therapeutics Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 180 Pages
  • Global
From
Autoimmune Drugs - Global Strategic Business Report - Product Thumbnail Image

Autoimmune Drugs - Global Strategic Business Report

  • Report
  • June 2025
  • 287 Pages
  • Global
From
Immunotherapy Drugs Market Size, Share & Trends by Type (mAb, Checkpoint Inhibitor, Interferon, Cancer Vaccine), Application (Cancer, Autoimmune, Inflammatory, Hematology, Neurology), Route of Administration (Intravenous, Subcutaneous), End User - Forecast to 2029 - Product Thumbnail Image

Immunotherapy Drugs Market Size, Share & Trends by Type (mAb, Checkpoint Inhibitor, Interferon, Cancer Vaccine), Application (Cancer, Autoimmune, Inflammatory, Hematology, Neurology), Route of Administration (Intravenous, Subcutaneous), End User - Forecast to 2029

  • Report
  • July 2024
  • 335 Pages
  • Global
From
Loading Indicator